European Urology Profile Banner
European Urology Profile
European Urology

@EUplatinum

Followers
39,610
Following
40
Media
3,426
Statuses
9,078

The Platinum Journal | Official Journal of EAU @Uroweb | Ranked #1 in Urology & Nephrology | Editor in Chief @Albert0Briganti | IF 25.3

Joined April 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@EUplatinum
European Urology
3 months
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 25.3, over 2 million website downloads, and 39.1k followers on Twitter we are constantly striving to be a cut above the rest! Thank you to our Authors, Reviewers, and Readership!
Tweet media one
0
18
58
@EUplatinum
European Urology
4 years
We're proud to continue leading the charge in academic Urology: new impact factor 17.947 Thank you to all of our readers, authors, reviewers, and editors! @JimCatto @Els_Urology
Tweet media one
11
55
303
@EUplatinum
European Urology
2 years
Sarah Psutka on the most efficient approach to writing a manuscript. #EAU22 #urology
Tweet media one
7
87
292
@EUplatinum
European Urology
2 years
We and @Uroweb are delighted to announce that Alberto Briganti @Albert0Briganti will replace @JimCatto as our new Editor in Chief of @EUplatinum Thank you to all the team who worked so hard to take us this far and we look forward to new horizons.
32
36
275
@EUplatinum
European Urology
3 years
New Platinum Editorial from @KBGinsburg @jpschober @uretericbud Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?
Tweet media one
8
64
189
@EUplatinum
European Urology
10 months
In loving memory of Urs Studer. Our thoughts are with his family, friends, and all who were touched by his remarkable contributions to Urology. Thank you for influencing urologists and how we practice urology today.
Tweet media one
15
43
181
@EUplatinum
European Urology
6 years
No difference in RFS, CSS or OS for Extended vs Limited Lymph Node Dissection in #bladdercancer Patients Undergoing Radical Cystectomy: A Prospective, Randomized Trial @TU_Muenchen @AStenzl #blcsm #VisualAbstract
Tweet media one
9
159
176
@EUplatinum
European Urology
3 years
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma @Uroweb @Els_Urology #eauguidelines @MattMilowsky @MariaJRibal
Tweet media one
2
94
175
@EUplatinum
European Urology
4 years
We are DELIGHTED to welcome Dr. Sarah Psutka as the newest member of our Editorial team! @spsutkaMD @uwurology @Uroweb @Els_Urology @SWIUorg
Tweet media one
20
8
164
@EUplatinum
European Urology
3 years
We are delighted to add @ERPlimackMD as our new Medical Oncology Editor! Dr. Plimack is a Professor of Medical Oncology, Chief of the Division of Genitourinary Medical Oncology and Director of Genitourinary Clinical Research at @FoxChaseCancer
Tweet media one
9
26
162
@EUplatinum
European Urology
3 years
January 2022 Issue The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
Tweet media one
0
75
155
@EUplatinum
European Urology
2 years
Huge congratulations to @JimCatto for receiving The EAU Frans Debruyne Life Time Achievement Award #EAU23
Tweet media one
Tweet media two
14
20
155
@EUplatinum
European Urology
1 year
Congratulations to @wandering_gu on receiving the European Urology Platinum Award #EAU23
Tweet media one
8
6
153
@EUplatinum
European Urology
5 years
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401) #prostatecancer
Tweet media one
1
84
148
@EUplatinum
European Urology
5 years
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation @JelleBarentsz @ProfPadhani
Tweet media one
0
84
149
@EUplatinum
European Urology
4 years
Best of 2020 Visual Abstracts 🏆1st Place🏆 #VisualAbstract Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma Congrats! @BBhindi @sandysrimd @montypal @DrChoueiri @brian_rini @DrDanielHeng et al.
Tweet media one
2
52
145
@EUplatinum
European Urology
11 months
Oligometastatic Bladder Cancer: Defining a Novel Entity @Chrislabaki1 @eddy_saad @DrChoueiri @OncoBellmunt #bladdercancer
Tweet media one
0
63
138
@EUplatinum
European Urology
4 years
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update #VisualAbstract @Uroweb @MRoupret @DrShariat @ThoSeisen @paolo_gontero @joanfundi @BPeyronnet
Tweet media one
4
77
146
@EUplatinum
European Urology
2 years
The Role of Stereotactic Ablative Body Radiotherapy in RCC @_ShankarSiva @lawrentschuk @DrRanaMcKay SABR: local control rate (LCR) >90% with Gr 3–4 toxicity 0–9% LCR: 90%-97% in intracranial mRCC SABR: delayed systemic Rx > 1 yr in 70–90% oligomet RCC
Tweet media one
3
75
147
@EUplatinum
European Urology
3 years
Please join us in welcoming @piet_ost as our new Radiation Oncology Editor! Dr. Ost is an associate professor at Ghent University and radiation oncologist at the Iridium Network, Antwerp, Belgium @Uroweb @EurUrolOncol @EurUrolFocus @EurUrolOpen
Tweet media one
19
20
145
@EUplatinum
European Urology
5 years
Updated @Uroweb Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma #VisualAbstract @AlbigesL @Uromigos @MichaelStaehler
Tweet media one
1
98
145
@EUplatinum
European Urology
6 years
Active Surveillance for Low-risk #ProstateCancer : The European Association of Urology Position in 2018 #VisualAbstract @Uroweb
Tweet media one
0
101
138
@EUplatinum
European Urology
6 years
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations @zklaassen_md et al
Tweet media one
Tweet media two
2
103
138
@EUplatinum
European Urology
5 years
Tweet media one
2
76
138
@EUplatinum
European Urology
2 years
Incorporating PSMA PET in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer @LauraBukavinaMD @AmyLuckenbaugh @DrMHofman @sophia_kamran @declangmurphy @KOSJ12 @piet_ost
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
59
136
@EUplatinum
European Urology
2 years
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
49
138
@EUplatinum
European Urology
4 years
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma #VisualAbstract @BBhindi @DrDanielHeng @DrChoueiri @montypal @brian_rini @ZiadBakouny @sandysrimd
Tweet media one
4
65
135
@EUplatinum
European Urology
4 years
Reporting Radical Cystectomy Outcomes Following Implementation of ERAS Protocols: A Systematic Review and Individual Patient Data Meta-Analysis #VisualAbstract @SWilliams_MD @siadaneshmand @JimCatto @marcuskwesi @UroDocAsh @pcvblack @WesKassouf
Tweet media one
3
59
132
@EUplatinum
European Urology
4 years
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology #VisualAbstract @VickersBiostats @f2harrell @statistishdan
Tweet media one
0
65
133
@EUplatinum
European Urology
4 years
January 2021 Issue European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update @Uroweb #eauguidelines #VisualAbstract
Tweet media one
2
58
128
@EUplatinum
European Urology
5 years
Structured Population-based Prostate-specific Antigen Screening for #ProstateCancer : The European Association of Urology Position in 2019
Tweet media one
6
104
130
@EUplatinum
European Urology
3 years
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography @VHMeissner
Tweet media one
18
48
128
@EUplatinum
European Urology
4 years
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy @jleow @OncoBellmunt @tompowles1
Tweet media one
2
68
125
@EUplatinum
European Urology
6 years
Multiparametric Magnetic Resonance Imaging for #BladderCancer : Development of VI-RADS (Vesical Imaging-Reporting And Data System)
Tweet media one
Tweet media two
1
98
123
@EUplatinum
European Urology
6 years
Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized #prostatecancer #visualabstract @BrighamWomens
Tweet media one
4
103
118
@EUplatinum
European Urology
2 years
Young Age on Starting PSA Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial @SigridCarlsson @VickersBiostats et al.
Tweet media one
Tweet media two
2
52
117
@EUplatinum
European Urology
4 years
September 2020 Issue Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines
Tweet media one
1
63
118
@EUplatinum
European Urology
4 years
Randomized Phase III Trial of dd-MVAC, or GC as Perioperative Chemotherapy for Pts with MIBC. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses #VisualAbstract
Tweet media one
0
77
112
@EUplatinum
European Urology
4 years
Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort #VisualAbstract @UroOncMD @MichaelASJewett @dougcheung @FleshnerNeil @siemensr @marty_gleave @SiTanguay
Tweet media one
0
51
116
@EUplatinum
European Urology
2 years
August 2022 Issue Radical Prostatectomy Without Prior Biopsy Following mpMRI and PSMA PET Editorial: Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative?
Tweet media one
15
45
114
@EUplatinum
European Urology
3 years
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes @GottfridSjodahl @UroLiedberg "Urothelial cancer of the luminal-like subtypes is more responsive to cisplatin-based neoadjuvant chemotherapy"
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
42
115
@EUplatinum
European Urology
5 years
Prostate imaging may miss over half of all prostate tumors and up to a third of all clinically significant tumors
Tweet media one
8
57
114
@EUplatinum
European Urology
3 years
Stereotactic RT for Oligoprogression in mRCC Pts Receiving TKI Therapy: Phase 2 Prospective Multicenter Study @sarehkeshavarzi @SahgalArjun "Local control of irradiated oligoprogressive mRCC tumors was high; change in therapy was delayed for median >1 yr"
Tweet media one
Tweet media two
Tweet media three
2
52
114
@EUplatinum
European Urology
5 years
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update @Uroweb
Tweet media one
2
66
112
@EUplatinum
European Urology
5 years
Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails
1
47
112
@EUplatinum
European Urology
4 years
Although we're supposed to be in Amsterdam at EAU, #COVID19 won't stop the @EUplatinum editorial board from meeting! First Virtual Editorial Board Meeting @Uroweb #EAU20
Tweet media one
4
17
112
@EUplatinum
European Urology
1 year
Congratulations to @MaartenAlbersen on receiving the European Urology Platinum Award #EAU23
Tweet media one
14
5
107
@EUplatinum
European Urology
4 years
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial #VisualAbstract @jeanlestingi @qdtrinh @RafaelFCoelho2
Tweet media one
1
46
106
@EUplatinum
European Urology
3 years
During another challenging year, we are incredibly grateful for the continued support of the Platinum Journal. Thank you to our Editors, Reviewers, and Readership! @Uroweb @Els_Urology
Tweet media one
3
23
107
@EUplatinum
European Urology
1 year
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 23.4, over 2 million website downloads, and 36.7k followers on Twitter we are constantly striving to be a cut above the rest!  Thank you to our Authors, Reviewers, and Readership!
Tweet media one
7
22
107
@EUplatinum
European Urology
6 years
The Microbiome and Genitourinary Cancer: A Collaborative Review
Tweet media one
0
59
104
@EUplatinum
European Urology
2 years
Single-port Robotic Transvesical Partial Prostatectomy for Localized Prostate Cancer: Initial Series and Description of Technique @drjkaouk @EricKleinMD @Purysko @KavianiMd @mohameddmagdyy
Tweet media one
Tweet media two
5
22
104
@EUplatinum
European Urology
4 years
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines @_alelarcher @u_capitanio @F_Montorsi @GFallara_MD @GianmarcoColand
Tweet media one
3
54
103
@EUplatinum
European Urology
5 years
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) @EBMUrology @dr_coops
Tweet media one
1
61
104
@EUplatinum
European Urology
4 years
Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial @AbtDominik @daniel_engeler @GautierMuellhau
Tweet media one
3
45
101
@EUplatinum
European Urology
6 years
Online Professionalism—2018 Update of European Association of #Urology ( @Uroweb ) Recommendations on the Appropriate Use of Social Media @HendrikBorgmann @JimCatto @uretericbud #eauguidelines #eau19 #SoMe
Tweet media one
0
74
103
@EUplatinum
European Urology
3 years
New Words of Wisdom from @d_magee22 @uretericbud Re: Adjuvant Pembrolizumab After Nephrectomy in Renal-cell Carcinoma
Tweet media one
2
32
103
@EUplatinum
European Urology
5 years
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort #VisualAbstract @UroDocJT @michael_gorin #prostatecancer
Tweet media one
0
60
100
@EUplatinum
European Urology
6 years
Analysis of >2,000 bladder carcinoma shows 6 molecular subtypes with distinct pathways and targetable vulnerability
Tweet media one
0
53
98
@EUplatinum
European Urology
2 years
At this time each year, we thank our outstanding editors, reviewers, authors, support staff, and readers for making the Platinum Journal the premier Urology & Nephrology peer-reviewed journal Thank you! 🙏🎆 @JimCatto @Els_Urology
Tweet media one
3
20
96
@EUplatinum
European Urology
4 years
Normally, this time of year we would be celebrating the announcement of our IF. This year is different. Instead, we give thanks to everyone in the European Urology community who continue to work tirelessly during these difficult times @EurUrolOncol @EurUrolFocus @EurUrolOpen
Tweet media one
1
24
97
@EUplatinum
European Urology
6 years
68Ga-PSMA-PET in Advanced #ProstateCancer —Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of PSMA-avid Lesions: A Systematic Review and Meta-analysis @drMPerera @declangmurphy @lawrentschuk @dan_christidis #VisualAbstract #pcsm
Tweet media one
2
61
96
@EUplatinum
European Urology
4 years
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized PCa: An International Multidisciplinary Consensus @AmirLebastchi @arvinkgeorge @ThomasPolascik @michael_gorin @RSanchezSalas @PChoyke
Tweet media one
1
48
96
@EUplatinum
European Urology
6 years
Head-to-head Comparison of TRUS Prostate Biopsy Versus mpMRI with Subsequent MR-guided Biopsy in Biopsy-naïve Men with Elevated PSA: A Large Prospective Multicenter Clinical Study @radboudumc #VisualAbstract
Tweet media one
3
60
94
@EUplatinum
European Urology
6 years
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
60
92
@EUplatinum
European Urology
3 years
Congratulations to our October 2021 Reviewer of the Month: Neeraj Agarwal! @neerajaiims
Tweet media one
3
20
94
@EUplatinum
European Urology
3 years
New Research Letter: Short-course 177Lu-PSMA-617 Radioligand Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer: Time to Take the Leap?
Tweet media one
0
39
92
@EUplatinum
European Urology
4 years
August 2020 Issue What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort #VisualAbstract Editorial:
Tweet media one
2
39
93
@EUplatinum
European Urology
6 years
Posterior, Anterior, and Periurethral Surgical Reconstruction of Urinary Continence Mechanisms in Robot-assisted Radical Prostatectomy: A Description and Video Compilation of Commonly Performed Surgical Techniques #ProstateCancer
Tweet media one
0
62
90
@EUplatinum
European Urology
5 years
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 @apccc19 @Silke_Gillessen @AOmlin @onco_uroloog @AlbertoBossial @Prof_IanD @mattsydes @ChrisSweens1 #apccc19 #prostatecancer
Tweet media one
0
51
90
@EUplatinum
European Urology
4 years
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians @amerseburger @scserendipity1 @MariaJRibal @SvenPerner @cnsternberg @quimmateo @ProfWirth @Dolmos77 @DanielPetrylak
Tweet media one
Tweet media two
1
39
90
@EUplatinum
European Urology
6 years
We are pleased to announce that Todd Morgan has joined European Urology as an Associate Editor: Welcome to the team, Todd @wandering_gu
Tweet media one
5
11
89
@EUplatinum
European Urology
5 years
Updated @Uroweb Guidelines on RCC: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic ccRCC @Uromigos @MichaelStaehler @RachelGiles6 @milanhoraplzen @amerseburger @foxal72 #VisualAbstract #kcsm #kidneycancer
Tweet media one
0
49
85
@EUplatinum
European Urology
5 years
Medical Expulsive Therapy for Urinary Stones: Future Trends and Knowledge Gaps @vdconinck @MattBultitude @JodiAntonelli @DrBenChew @SkolarikosAndre #VisualAbstract
Tweet media one
2
38
86
@EUplatinum
European Urology
4 years
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on PCa—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent #VisualAbstract @Uroweb @officialEANM @ESTRO_RT @EsurOffice @philcornford @marcuskwesi @Nicola_Fossati @Silke_Gillessen
Tweet media one
0
55
85
@EUplatinum
European Urology
7 years
Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind Placebo-controlled Trial
4
86
87
@EUplatinum
European Urology
4 years
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial #VisualAbstract @DrMHofman @jhsyim @mfrydenberg @lawrentschuk @declangmurphy
Tweet media one
0
41
87
@EUplatinum
European Urology
6 years
MRI of the prostate has high negative predictive value, but biopsy cannot still be avoided after negative MRI
2
67
86
@EUplatinum
European Urology
6 years
External Beam Radiotherapy Increases the Risk of #BladderCancer When Compared with Radical Prostatectomy in Patients Affected by #ProstateCancer : A Population-based Analysis @UroMoschini
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
81
85
@EUplatinum
European Urology
6 years
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update @Uroweb
Tweet media one
2
58
85
@EUplatinum
European Urology
6 years
First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis @WallisCJD et al
Tweet media one
1
63
84
@EUplatinum
European Urology
11 months
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty
Tweet media one
3
55
83
@EUplatinum
European Urology
5 years
Video compilation of surgical techniques for urinary incontinence in RARP
Tweet media one
1
29
81
@EUplatinum
European Urology
4 years
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial #VisualAbstract @motzermd @cnsternberg @brian_rini @DrChoueiri @AStenzl
Tweet media one
1
35
82
@EUplatinum
European Urology
6 years
Tweet media one
2
54
84
@EUplatinum
European Urology
4 years
NPV of mpMRI in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis #VisualAbstract @NiranjanJS @LambAlastair @JimCatto @declangmurphy @mrsprostate
Tweet media one
0
46
84
@EUplatinum
European Urology
5 years
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019 @Uroweb @GGandaglia #VisualAbstract
Tweet media one
1
52
83
@EUplatinum
European Urology
4 years
New In Press EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer @Uroweb @ESTRO_RT @EsurOffice @SIOGorg @philcornford @Dr_Willemse @marcuskwesi @mdesantis234 @Nicola_Fossati
Tweet media one
0
49
81
@EUplatinum
European Urology
2 years
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
39
82
@EUplatinum
European Urology
6 years
Duration of Androgen Deprivation Therapy in High-risk #ProstateCancer : A Randomized Phase III Trial #VisualAbstract
Tweet media one
0
62
82
@EUplatinum
European Urology
4 years
October 2020 Issue Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
Tweet media one
1
41
79
@EUplatinum
European Urology
3 years
December 2021 Issue The Additive Diagnostic Value of PSMA PET/CT to mpMRI Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study "PSMA + MRI improved NPV and sensitivity for csPCa in an MRI triaged population"
Tweet media one
Tweet media two
1
30
81
@EUplatinum
European Urology
4 months
Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer Read the full article here: @aherlema @dr_coops #UroSoMe #Medtwitter #PCa
Tweet media one
1
37
80
@EUplatinum
European Urology
6 years
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes
Tweet media one
1
76
81
@EUplatinum
European Urology
2 years
Best Scientific Paper 2022: Louise Emmett et al for their paper, "The Additive Diagnostic Value of Prostate-specific Membrane Antigen PET Computed Tomography to Multiparametric MRI Triage in the Diagnosis of PCa (PRIMARY): A Prospective Multicentre Study" Congratulations!
Tweet media one
3
20
80
@EUplatinum
European Urology
8 months
The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial by Alexander Light et al #prostatecancer #Medtwitter #UroSoMe
Tweet media one
1
30
79
@EUplatinum
European Urology
4 years
March 2021 Issue Updated EAU Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma #VisualAbstract @Uroweb #eauguidelines
Tweet media one
0
38
79
@EUplatinum
European Urology
4 years
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial #VisualAbstract @HitenDPatel @allaf_mo @farzanafais @cpavmd @drphil_urology @michael_gorin @misophan @alan_partin
Tweet media one
0
34
80
@EUplatinum
European Urology
4 years
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines @Uroweb @MariaJRibal
Tweet media one
2
38
79